Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment with anti-KIR3DL2 agents

Treatment with anti-KIR3DL2 agents

US Patent 11970535 · Granted Apr 30, 2024

Estimated economic value: $190,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of T cell lymphoma2025
NKp46 binding agents2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Treatment regimens using anti-NKG2A antibodies2024
Treatment of peripheral T cell lymphoma2024
CD73 blockade2024
KIR3DL2 binding agents2024
KIR3DL2 binding agents2024
Compositions and methods for treating cancer2023
Neutralization of inhibitory pathways in lymphocytes2023
NKp46 binding agents2022